These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1922232)

  • 1. Fluconazole and Candida krusei fungemia.
    Persons DA; Laughlin M; Tanner D; Perfect J; Gockerman JP; Hathorn JW
    N Engl J Med; 1991 Oct; 325(18):1315. PubMed ID: 1922232
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluconazole resistance of Candida krusei.
    Manso E; Montillo M; Discepoli G; Leoni P
    Boll Ist Sieroter Milan; 1991-1992; 70(1-2):527-9. PubMed ID: 1670057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community-acquired fungemia due to a multiple-azole-resistant strain of Candida tropicalis.
    Jandourek A; Brown P; Vazquez JA
    Clin Infect Dis; 1999 Dec; 29(6):1583-4. PubMed ID: 10585825
    [No Abstract]   [Full Text] [Related]  

  • 4. [Candida albicans fungemia with pulmonary localization treated with fluconazole. A case report].
    Thomas F; Mebtouche B; Clavier H; Kalfon P
    Rev Pneumol Clin; 2000 Feb; 56(1):37-40. PubMed ID: 10740113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution and antifungal susceptibility of Candida species causing candidemia from 1996 to 1999.
    Cheng MF; Yu KW; Tang RB; Fan YH; Yang YL; Hsieh KS; Ho M; Lo HJ
    Diagn Microbiol Infect Dis; 2004 Jan; 48(1):33-7. PubMed ID: 14761719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activities of fluconazole and voriconazole against bloodstream isolates of Candida glabrata and Candida krusei: a 14-year study in a Spanish tertiary medical centre.
    Quindós G; Sánchez-Vargas LO; Villar-Vidal M; Eraso E; Alkorta M; Hernández-Almaraz JL
    Int J Antimicrob Agents; 2008 Mar; 31(3):266-71. PubMed ID: 18054468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergency of fungemia cases caused by fluconazole-resistant Candida auris in Beijing, China.
    Chen Y; Zhao J; Han L; Qi L; Fan W; Liu J; Wang Z; Xia X; Chen J; Zhang L
    J Infect; 2018 Dec; 77(6):561-571. PubMed ID: 30219662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
    Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
    Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Phagocytosis of fungi in the peripheral blood neutrophils of two children with cancer during treatment with fluconazole].
    Manabe A; Ebihara Y; Saito A; Takahashi K; Hosoya R
    Rinsho Ketsueki; 1997 Aug; 38(8):669-73. PubMed ID: 9311273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological advances in the treatment of invasive candidiasis.
    Deck DH; Guglielmo BJ
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):137-49. PubMed ID: 16441215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluconazole prophylaxis and Candida fungemia in neutropenic children with malignancies.
    Cesaro S; Rossetti F; Perilongo G; Rossi L; Zanesco L
    Haematologica; 1993; 78(4):249-51. PubMed ID: 8294059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of candidemia.
    Tang CM; Howe P; Crook DW
    N Engl J Med; 1995 Apr; 332(16):1101; author reply 1101-2. PubMed ID: 7898539
    [No Abstract]   [Full Text] [Related]  

  • 13. Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia.
    Shorr AF; Lazarus DR; Sherner JH; Jackson WL; Morrel M; Fraser VJ; Kollef MH
    Crit Care Med; 2007 Apr; 35(4):1077-83. PubMed ID: 17312565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outbreak of fungemia among neonates caused by Candida haemulonii resistant to amphotericin B, itraconazole, and fluconazole.
    Khan ZU; Al-Sweih NA; Ahmad S; Al-Kazemi N; Khan S; Joseph L; Chandy R
    J Clin Microbiol; 2007 Jun; 45(6):2025-7. PubMed ID: 17428940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of breakthrough fungemia caused by azole-resistant Candida tropicalis in patients with hematologic malignancies.
    Myoken Y; Kyo T; Fujihara M; Sugata T; Mikami Y
    Haematologica; 2004 Mar; 89(3):378-80. PubMed ID: 15020289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluconazole and Candida krusei fungemia.
    Girmenia C; Pagano L; Leone G; Martino P
    Arch Intern Med; 2001 Oct; 161(18):2267-9. PubMed ID: 11575996
    [No Abstract]   [Full Text] [Related]  

  • 17. Fluconazole-resistant Candida albicans in an immunocompetent child.
    Hennequin C; Labenne M; Benkerrou M; Hambourg M
    Clin Infect Dis; 1994 Dec; 19(6):1179-80. PubMed ID: 7888572
    [No Abstract]   [Full Text] [Related]  

  • 18. [Candida krusei (Castellani) Berkhout--a potential pathogen with growing importance].
    Otcenásek M; Buchta V
    Epidemiol Mikrobiol Imunol; 1998 Dec; 47(4):137-40. PubMed ID: 9919813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of fungemia due to Candida krusei.
    Mori T; Inamori K; Matsumura M; Oguri T; Oshimi K
    Nihon Ishinkin Gakkai Zasshi; 1999; 40(1):15-20. PubMed ID: 9929577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid identification of fluconazole resistance using Chrom agar Candida.
    Verghese SL; Padmaja P; Sutha P; Mathew T; Johni ES
    Indian J Pathol Microbiol; 2001 Jul; 44(3):305-7. PubMed ID: 12024918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.